Literature DB >> 20225175

[Pharmacotherapy of neuropsychiatric symptoms in dementia in nursing homes: a comparison of service provision by psychiatric outpatient clinics and primary care psychiatrists].

Michael A Rapp1, Tomislav Majic, Jan-Paul Pluta, Thomas Mell, Jan Kalbitzer, Yvonne Treusch, Andreas Heinz, Hans Gutzmann.   

Abstract

BACKGROUND: Neuropsychiatric symptoms of dementia like agitation, depression and apathy often result in increased prescriptions of psychotropics. In Germany, outpatient clinics at psychiatric hospitals play an important role in the treatment of neuropsychiatric symptoms in nursing homes. The aim of this study was to test whether the severity and pharmacotherapy differed in patients treated by outpatient clinics at psychiatric hospitals, as compared to primary care specialists.
METHODS: A cross-sectional study of the prevalence of agitation, apathy, and depression, and the amount of psychotropics prescribed in defined daily dosages (DDD) in 304 residents with dementia in 18 Berlin nursing homes.
RESULTS: Patients treated by outpatient clinics at psychiatric hospitals suffered from more severe neuropsychiatric symptoms (p < 0.05), were prescribed more antidepressants and antidementia agents (p < 0.05) and, when adjusting for the severity of agitation, less neuroleptics (p < 0.05) as compared to primary care specialists.
CONCLUSION: Psychiatric outpatient clinics at hospitals treat more severely demented patients who suffer from severe neuropsychiatric symptoms. The pharmacotherapy provided by these clinics displays a favourable profile according to established treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225175     DOI: 10.1055/s-0029-1223475

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany.

Authors:  Philipp Hessmann; Jan Zeidler; Jona Stahmeyer; Sveja Eberhard; Jonathan Vogelgsang; Mona Abdel-Hamid; Claus Wolff-Menzler; Jens Wiltfang; Bernhard Kis
Journal:  Front Pharmacol       Date:  2019-07-24       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.